Ivicentamab Biosimilar - Research Grade

In stock
Only %1 left
SKU
ICH5612
Add to Compare
$710.00 - $6,900.00
Delivery Time : 4 weeks

Ivicentamab Biosimilar - Research Grade

Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>90% by SDS-PAGE
Species Reactivity
Human
Target
CD37ï؟½
Concentration
5mg/ml
Isotype
IgG1 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH3002
Uniprot
P11049
Shipping Conditions
Blue ice
Background
Tetraspanin CD37 is abundant on mature B cells and is widely investigated as a target in hematologic malignancy research. Recognizing the human antigen, this human IgG1, kappa reagent is an unconjugated, non-therapeutic analog of ivicentamab, provided strictly for research use only (RUO). Its low-endotoxin formulation is suitable for in vivo work, and production spans milligram to gram quantities to keep heavy-usage and bulk facilities adequately stocked. Researchers deploy it in cell-binding and flow-cytometry assays, ADCC studies, in vitro screening, and preclinical lymphoma models, where it provides a consistent reference reagent during functional evaluation and antibody development.
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
3-4 weeks
Write Your Own Review
You're reviewing:Ivicentamab Biosimilar - Research Grade
Your Rating
Back to Top